Stetson

24%
Flag icon
And industry is doing all this for free. As in the Ebola crisis and other pandemics, biopharma companies have banded together to do what must be done, with no fanfare and no publicity. They should get full credit for their efforts. These companies are hardly perfect—just like the rest of us—but politicians who find them an easy target should open their minds and put down their cudgels. It is equally the job of reporters at mass-market business and consumer media to open their minds and understand and report on how the world really works, and who will ultimately provide the solutions to today’s ...more
Biotechnology in the Time of COVID-19: Commentaries from the Front Line
Rate this book
Clear rating